{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-034716","form_type":"8-K","ticker":"IMNN","cik":"0000749647","company_name":"Imunon, Inc.","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.778409+00:00","generated_at":"2026-05-31T06:42:54.558612+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Imunon resumes at-the-market stock offering after previous suspension","bullets":["On Sept 3, 2024, Imunon filed a new prospectus supplement to resume sales under the existing ATM agreement.","The ATM program had been suspended on July 30, 2024 via termination of the sales prospectus.","The ATM Agreement (May 2022, amended May 2024) with H.C. Wainwright remains in force.","Legal opinion on share validity from Covington & Burling filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-034716","json":"https://secwatch.observer/filing/0001493152-24-034716.json","markdown":"https://secwatch.observer/filing/0001493152-24-034716.md","text":"https://secwatch.observer/filing/0001493152-24-034716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/749647/000149315224034716/0001493152-24-034716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/749647/000149315224034716/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:42:54.558612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}